Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
3.640
-0.120 (-3.19%)
At close: Oct 28, 2025, 4:00 PM EDT
3.610
-0.030 (-0.82%)
After-hours: Oct 28, 2025, 7:48 PM EDT
Cingulate Market Cap
Cingulate has a market cap or net worth of $20.41 million as of October 28, 2025. Its market cap has increased by 50.64% in one year.
Market Cap
20.41M
Enterprise Value
18.09M
1-Year Change
50.64%
Ranking
Category
Stock Price
$3.64
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $20.41M, a decrease of -68.26%. That is a compound annual growth rate of -25.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 21.08M | 29.49% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |